Exact Mass: 752.1872
Exact Mass Matches: 752.1872
Found 53 metabolites which its exact mass value is equals to given mass value 752.1872
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
4-Acetylsagittatin A
Haploperoside C Acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.236 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.237 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.242 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.235
oxytroflavoside B|rhamnocitrin-3-O-[(S)-3-hydroxy-3-methylglutaryl-(1->3)]-[alpha-L-rhamnopyranosyl-(1->2)]-beta-D-galactopyranoside
oxytroflavoside C|rhamnocitrin-3-O-[(S)-3-hydroxy-3-methylglutaryl-(1->4)]-[alpha-L-rhamnopyranosyl-(1->2)]-beta-D-galactopyranoside
oxytroflavoside A|rhamnocitrin-3-O-[(S)-3-hydroxy-3-methylglutaryl-(1->6)]-[alpha-L-rhamnopyranosyl-(1->2)]-beta-D-galactopyranoside
2,3,4,6-tetra-O-acetylhenryoside|[2-(beta-D-glucopyranosyloxy)phenyl]methyl 6-hydroxy-2-[(2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl)oxy]benzoate
arillatose A|cyclic 3->3:6->2-[(1S,2R)-1-(4-hydroxy-3,5-dimethoxyphenyl)-1,2-dihydro-7-hydroxy-6,8-dimethoxy-2,3-naphthalenedicarbonyl]-beta-D-fructofuranosyl alpha-D-glucopyranoside
5-[[4,5-dihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-3-yl]oxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]methoxy]-3-hydroxy-3-methyl-5-oxopentanoic acid
5-[[4,5-dihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-3-yl]oxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]methoxy]-3-hydroxy-3-methyl-5-oxopentanoic acid
5-[[4,5-dihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-3-yl]oxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]methoxy]-3-hydroxy-3-methyl-5-oxopentanoic acid [IIN-based on: CCMSLIB00000848292]
5-[[4,5-dihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-3-yl]oxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]methoxy]-3-hydroxy-3-methyl-5-oxopentanoic acid [IIN-based: Match]
S- 4-oxide--hydroxy-2,6-bis[4-(2-naphthalenyl)phenyl]-Dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin
5,10,15,20-TETRAPHENYL-21H,23H-PORPHINE RUTHENIUM(II) CARBONYL
1-butyl-2-[2-[3-[(1-butyl-6-chlorobenz[cd]indol-2(1H)-ylidene)ethylidene]-2-chloro-5-methyl-1-cyclohexen-1-yl}ethenyl)-6-chlorobenz[cd]-indolium tetrafluoroborate
2,2,4-Tris(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-4,5-diphenyl-1,1-biimidazole
7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-({1-[2-(2-chloro-3,4-dihydroxybenzamido)ethyl]pyrrolidinium-1-yl}methyl)-3,4-didehydrocepham-4-carboxylic acid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use
N-[5-O-Phosphono-ribofuranosyl]-2-[2-hydroxy-2-[4-[glutamic acid]-N-carbonylphenyl]-3-[2-amino-4-hydroxy-quinazolin-6-YL]-propanylamino]-acetamide
7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-3-[[1-[2-[(2-chloro-3,4-dihydroxybenzoyl)amino]ethyl]pyrrolidin-1-ium-1-yl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(2S,4S,5R,6R)-5-acetamido-2-[(2R,3R,4R,5R,6S)-6-[(2R,3S,4R,5R)-5-acetamido-4,6-dihydroxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate
(10e,11e)-6,16,17,18-tetrahydroxy-10,11-bis[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-3,5-bis(hydroxymethyl)-2,4,8,13,19-pentaoxatricyclo[13.3.1.0³,⁷]nonadecane-9,12-dione
(3s)-3-hydroxy-5-{[(2r,3r,4s,5r,6s)-4-hydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-3-yl]oxy}-2-(hydroxymethyl)-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxy}-3-methyl-5-oxopentanoic acid
(1r,3s,5r,6r,7s,10e,11e,15r,16r,17s,18r)-6,16,17,18-tetrahydroxy-10,11-bis[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-3,5-bis(hydroxymethyl)-2,4,8,13,19-pentaoxatricyclo[13.3.1.0³,⁷]nonadecane-9,12-dione
4-{4-[3-chloro-2-hydroxy-4-(1-hydroxy-2-methoxy-3,6-dimethyl-4-oxocyclohexa-2,5-diene-1-carbonyloxy)-5,6-dimethylbenzoyloxy]-2-hydroxy-3,6-dimethylbenzoyloxy}-6-methoxy-2,3-dimethylbenzoic acid
arillatose a
{"Ingredient_id": "HBIN016744","Ingredient_name": "arillatose a","Alias": "NA","Ingredient_formula": "C34H40O19","Ingredient_Smile": "COC1=CC(=CC(=C1O)OC)C2C3C(=CC4=CC(=C(C(=C24)OC)O)OC)C(=O)OC5C(C(OC5(OC6C(C(C(C(O6)COC3=O)O)O)O)CO)CO)O","Ingredient_weight": "752.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1684","TCMSP_id": "NA","TCM_ID_id": "6680","PubChem_id": "21606606","DrugBank_id": "NA"}